4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001568249-26-000005
EVP, CHIEF LEGAL OFFICER, SEC sold 3,844 shares at $21.47 ($82,531)
- EVP, CHIEF LEGAL OFFICER, SEC acquired 7,515 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Rhodes Jennifer J · EVP, CHIEF LEGAL OFFICER, SEC
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-24 | Exercise or conversion : show line 1 in the form | +7,515 | 15,124 | D | ||
| 2026-03-25 | Sale : show line 2 in the form | −3,844 | $21.47 | $82,531 | 11,280 | D |
| Open-market sales · 3,844 sh · avg $21.47 · $82,531 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-24 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −7,515 | 22,547 | D |
Loading xslF345X06/form4-03262026_080308.xml…